Stock Evaluator: Alcon Inc. (ALC)

Alcon Inc. ALC

$74.26 0.71 0.97%
August 19, 2026 4:00:02 PM EST November 10, 2021 Volume: 1,652,460
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Commentary & Analysis


Financial Summary

Share Statistics ALC Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $35,383.7 $425.3 91%
Shares Out (Mil) 488.7 41.5 88%
Institutional Ownership 99.7% 81.8% 92%
Float (Mil) 481.8 34.9 85%
Beta 0.69 0.88 41%
Avg Daily Volume (000s) 2,193 416 83%
Price Change
(52-week)
(15.7%) 66.9% 32%
Growth ALC Industry
Median
Percentile
(All Stocks)
Sales (5yr) 8.8% 11.8% 54%
Net Income (5yr) 30.9% (5.8%) 85%
EPS (5yr) 30.7% 10.4% 82
Dividends (5yr) 25.6% 0.0% 66%
Cash Flow (5yr) (17.1%) (16.2%) 41%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na 24 25
Current EPS na $3.497 $3.975
Month Ago EPS na $3.467 $3.971
# Rev Up na 0 0
# Rev Down na 1 1
Three Months Ago EPS na $3.465 $3.964
Year/Year Chg na 76.6% 128.6%
Financials ALC Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $10,861 $123 85%
Net Income (TTM) (Mil) $643 ($9) 82%
EPS (TTM) $1.315 ($0.400) 64%
Operating Cash Flow (TTM) (Mil) $2,310 ($3) 89%
Net Cash Flow (TTM) (Mil) ($53) $1 19%
Long-Term Debt (Q1) (Mil) $4,648 $21 85%
Enterprise Value (Q1) (Mil) $39,108 $542 90%
Valuation ALC Industry
Median
Percentile
(All Stocks)
P/B 1.66 3.13 43%
P/E 56.6 28.5 86%
Dividend Yield 0.4% 0.0% 62%
PEG (5yr hist) 1.8 1.7 65%
Ratios ALC Industry
Median
Percentile
(All Stocks)
Gross Margin 57.2% 58.7% 70%
Net Margin 5.9% (6.9%) 51%
ROA 2.1% (12.3%) 56%
ROE 2.9% (12.3%) 40%
Liabilities to Assets 30.6% 46.0% 22%
F-Score 7 4 82%

Alcon Inc. did not pass any screens on 8/19/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors